What is Erlotinib (Tarceva)?
Erlotinib (Tarceva, Genentech), is a targeted cancer treatment approved for treating chemotherapy-resistant advanced non-small cell lung cancer (NSCLC). NSCLC is the most frequent cause of cancer death...
View ArticleClinical Trials of Erlotinib (Tarceva) in Treatment of Advanced Non-Small...
Non-small cell lung cancer (NSCLC) features among the leading cause of cancer mortality all over the world. New molecular targeted therapies like Erlotinib, is the need for improving prognosis of lung...
View ArticleNon-Small Cell Lung Cancer Therapy Enhanced – Combination Of RNAi With...
New research published in the journal BMC Medicine, and titled, ‘Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with...
View ArticleClik here to view.
What is Erlotinib (Tarceva)?
Mechanism of action of Erlotinib (Tarceva) Erlotinib (Tarceva, Genentech), is a targeted cancer treatment approved for treating chemotherapy-resistant advanced non-small cell lung cancer (NSCLC)....
View ArticleClik here to view.
Clinical Trials of Erlotinib (Tarceva) in Treatment of Advanced Non-Small...
Non-small cell lung cancer treated using Erlotinib. Non-small cell lung cancer (NSCLC) features among the leading cause of cancer mortality all over the world. New molecular targeted therapies like...
View ArticleClik here to view.
Non-Small Cell Lung Cancer Therapy Enhanced – Combination Of RNAi With...
Combination of iRNA and TKI offer new dimensions to lung cancer therapy. Pic courtesy: http://www.nature.com/scitable/topicpage/gene-expression-14121669 New research published in the journal BMC...
View Article
